" class="no-js "lang="en-US"> Carrum Health Taps Pallav Sharda as Chief Platform Officer to Scale Technology Platform - Medtech Alert
Monday, October 02, 2023

Carrum Health Taps Pallav Sharda as Chief Platform Officer to Scale Technology Platform

Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered platform for higher quality and cost-effective surgical care, today announced it named Pallav Sharda as Chief Platform Officer. Bringing a unique blend of data science, product management and clinical expertise, Sharda will lead the team responsible for scaling Carrum Health’s technology platform as the company expands its provider base and procedures offered and sees growing demand from self-insured employers seeking cost-effective, high-quality care for their employees.

“At Carrum Health, we’ve built the highest quality network of Centers of Excellence and are leading the much-needed digital transformation of surgical care. This is only achievable through our plug-and-play technology platform that integrates data science and machine learning to ensure surgery is necessary and then guarantees the highest quality of care,” said Sach Jain, CEO and founder of Carrum Health. “With our platform, we virtualized almost every step of a surgical episode through our patient app while radically simplifying the adoption of COE programs for employers. Now is the time to change the way people experience healthcare, and I’m thrilled to welcome a leader of Pallav’s caliber to help drive forward our technology platform.”

Before joining Carrum Health, Sharda served as the Global Healthcare and Life Sciences Leader for Google Cloud and worked on healthcare projects at X, the R&D division of Google’s parent company, Alphabet. He taught graduate-level Medical Informatics courses at Northwestern University, and his book on Health IT innovation and entrepreneurship, “Before Disrupting Healthcare,” was published in June 2016. Trained as a physician, Sharda earned a master’s in Bioinformatics at Columbia University and spent his early career working in health IT product and engineering management for GE Healthcare. He then moved to the payor side of the industry, first serving as director of Advanced Analytics for Kaiser Permanente and then director of HIE Product Management for UnitedHealth Group. Sharda also was the Director of Interoperability and Partnerships at Omnicell and co-founded health IT startup Dovetail Care Inc.

At Carrum Health, Sharda will oversee engineering, product, data science and design to ensure that the evolving technology platform can effectively scale as the company’s member and provider bases grow. The company recently announced a strategic agreement with Vizient Inc., the nation’s largest healthcare performance improvement company. This agreement will give Carrum Health members greater access to quality care through high-value providers affiliated with Vizient member healthcare systems, which comprise more than half of the nation’s hospitals, including 97% of academic medical centers. Sharda and his team will play a pivotal role as the company enters a hyper-growth stage in 2021 and beyond.

“It’s one thing to bundle a hip or knee replacement, but to tackle a complex patient journey like cancer and incentivize some of the nation’s top cancer centers, like Memorial Sloan Kettering, to offer a two-year warranty on the care, that’s a game-changer,” said Sharda. “The Carrum technology platform is built from the ground up to support end-to-end care journeys and leverage data and AI to offer a modern, digital health experience to members as well as a single, seamless solution for employers. I look forward to working with Sach and the entire Carrum Health team to scale this technology to more employers, geographies and service offerings.” 

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more